Evidence map›Paper›PMID 20518720›Full record

ReviewExpert review of vaccines2010

The challenge of assessing infant vaccine responses in resource-poor settings.

Katie L Flanagan, Sarah Burl, Barbara L Lohman-Payne, Magdalena Plebanski

Abstract readReview
In one paragraph

Review in Expert review of vaccines, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Ontogeny of early life immunity.Trends in immunology · 2014
    Review
  8. Article
  9. Article
  10. Methods to measure vaccine immunity.Expert review of vaccines · 2010
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Katie L FlanaganMedical Research Council (UK) The Gambia, Fajara, The Gambia.
Sarah Burl
Barbara L Lohman-Payne
Magdalena Plebanski

Funding

Urgent Versus Post-Stabilization ART in HIV+ Children with Severe Co-infectionsR01HD023412 · NICHD · UNIVERSITY OF WASHINGTON · PI Grace C. John-Stewart, DALTON CHEKOKO WAMALWA · 1987 to 2026
$12.2M
Protective cellular immune responses in HIV-1 discordant couplesR01AI068431 · NIAID · UNIVERSITY OF WASHINGTON · PI FARQUHAR, CAREY · 2006 to 2010
$3.1M
Pediatric HIV-1 in Africa: Pathogenesis and ManagementK24HD054314 · NICHD · UNIVERSITY OF WASHINGTON · PI JOHN-STEWART, GRACE C. · 2006 to 2016
$1.2M
CTL responses in HIV-1 infected infantsK01TW006080 · FIC · UNIVERSITY OF WASHINGTON · PI PAYNE, BARBARA LOUISE · 2002 to 2005
$495k
FIC NIH HHS K01 TW006080Medical Research Council MC_U190088485NIAID NIH HHS AI068431NIAID NIH HHS R01 AI068431NICHD NIH HHS HD023412NICHD NIH HHS HD054314NICHD NIH HHS K24 HD054314NICHD NIH HHS R01 HD023412PHS HHS U62/CCU024512
6 · The paper itself

Abstract

Newborns and infants are highly susceptible to infectious diseases, resulting in high mortality and morbidity, particularly in resource-poor settings. Many vaccines require several booster doses, resulting in an extensive vaccine schedule, and yet there is still inadequate protection from some of these diseases. This is partly due to the immaturity of the neonate and infant immune system. Little is known about the specific modifications to immunological assessment protocols in early life but increasing knowledge of infant immunology has helped provide better recommendations for assessing these responses. Since most new vaccines will eventually be deployed in low-income settings such as Africa, the logistics and resources of assessing immunity in such settings also need to be understood. In this article, we will review immunity to vaccines in early life, discuss the many challenges associated with assessing immunogenicity and provide practical tips.

Indexed as

Adaptive ImmunityB-LymphocytesFemaleHumansImmunity, InnateInfantInfant, NewbornMaleSex CharacteristicsT-LymphocytesVaccinesVaccines

Identifiers

PMID20518720
PMCPMC2937226

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.